These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7531172)

  • 1. Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope.
    Tartakovsky F; Worman HJ
    Hepatology; 1995 Feb; 21(2):495-500. PubMed ID: 7531172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis.
    Bandin O; Courvalin JC; Poupon R; Dubel L; Homberg JC; Johanet C
    Hepatology; 1996 May; 23(5):1020-4. PubMed ID: 8621127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
    Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
    J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope.
    Wesierska-Gadek J; Hohenauer H; Hitchman E; Penner E
    Hum Antibodies Hybridomas; 1996; 7(4):167-74. PubMed ID: 9140728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
    Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
    Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear envelope protein autoantibodies in primary biliary cirrhosis.
    Courvalin JC; Worman HJ
    Semin Liver Dis; 1997 Feb; 17(1):79-90. PubMed ID: 9089913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an enzyme immune assay for detecting M2 autoantibodies specific for primary biliary cirrhosis.
    Jiang XH; Fang XY; Zhong RQ; Wang XP; Hu Y; Kong XT
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):290-4. PubMed ID: 14599987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis.
    Muratori P; Muratori L; Ferrari R; Cassani F; Bianchi G; Lenzi M; Rodrigo L; Linares A; Fuentes D; Bianchi FB
    Am J Gastroenterol; 2003 Feb; 98(2):431-7. PubMed ID: 12591064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.
    Nakamura M; Shimizu-Yoshida Y; Takii Y; Komori A; Yokoyama T; Ueki T; Daikoku M; Yano K; Matsumoto T; Migita K; Yatsuhashi H; Ito M; Masaki N; Adachi H; Watanabe Y; Nakamura Y; Saoshiro T; Sodeyama T; Koga M; Shimoda S; Ishibashi H
    J Hepatol; 2005 Mar; 42(3):386-92. PubMed ID: 15710222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigen.
    Xu J; Zhang H; Wang C; Jiang P; Han C; Dai Y; Qiu F; Gong Y; Jiang Y; Xu P; Zhang M; Zhang L; Shi X; Chen S; Tian Y; Seldin MF; Gershwin ME; Liu X; Li L
    J Immunol Methods; 2022 Feb; 501():113211. PubMed ID: 34971632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential detection of nuclear envelope autoantibodies in primary biliary cirrhosis using routine and alternative methods.
    Tsangaridou E; Polioudaki H; Sfakianaki R; Samiotaki M; Tzardi M; Koulentaki M; Panayotou G; Kouroumalis E; Castanas E; Theodoropoulos PA
    BMC Gastroenterol; 2010 Mar; 10():28. PubMed ID: 20205958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.
    Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL
    Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies.
    Wesierska-Gadek J; Klima A; Komina O; Ranftler C; Invernizzi P; Penner E
    Ann N Y Acad Sci; 2007 Aug; 1109():519-30. PubMed ID: 17785341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens.
    Miyakawa H; Tanaka A; Kikuchi K; Matsushita M; Kitazawa E; Kawaguchi N; Fujikawa H; Gershwin ME
    Hepatology; 2001 Aug; 34(2):243-8. PubMed ID: 11481607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope.
    Leung PS; Chuang DT; Wynn RM; Cha S; Danner DJ; Ansari A; Coppel RL; Gershwin ME
    Hepatology; 1995 Aug; 22(2):505-13. PubMed ID: 7543435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis.
    Nakamura M; Takii Y; Ito M; Komori A; Yokoyama T; Shimizu-Yoshida Y; Koyabu M; Matsuyama M; Mori T; Kamihira T; Daikoku M; Migita K; Yatsuhashi H; Nozaki N; Shimoda S; Ishibashi H
    J Autoimmun; 2006 Mar; 26(2):138-45. PubMed ID: 16337775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis.
    Nickowitz RE; Wozniak RW; Schaffner F; Worman HJ
    Gastroenterology; 1994 Jan; 106(1):193-9. PubMed ID: 8276182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the antibodies to p62 nucleoporin in primary biliary cirrhosis using human recombinant antigen.
    Wesierska-Gadek J; Klima A; Ranftler C; Komina O; Hanover J; Invernizzi P; Penner E
    J Cell Biochem; 2008 May; 104(1):27-37. PubMed ID: 17960595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.